Cart
sales@molnova.com
Erenumab
CAS No. 1582205-90-0
Erenumab( —— )
Catalog No. M36754 CAS No. 1582205-90-0
Erenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 324 | Get Quote |
|
| 5MG | 535 | Get Quote |
|
| 10MG | 842 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameErenumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionErenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks.
-
DescriptionErenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCGRP Receptor
-
RecptorCGRP Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1582205-90-0
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Goadsby PJ, Reuter U, Hallstr?m Y, et al. A Controlled Trial of Erenumab for Episodic Migraine.?N Engl J Med. 2017;377(22):2123-2132.?
molnova catalog
related products
-
Olcegepant (hydrochl...
The first small molecule selective CGRP antagonist with Ki of 14.4 nM for hCGRP.
-
Erenumab
Erenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks.
-
MK-0974
A potent, selective, orally bioavailable CGRP receptor antagonist with Ki of 0.77 nM.
